Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ARVN Arvinas Inc
- Stocks
- Healthcare
- NASDAQ: ARVN
Price (delayed)
$6.07
Market cap
$443.06M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.66
Enterprise value
$372.56M
Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing
Highlights
The EPS has soared by 89% YoY and by 76% from the previous quarter
The company's net income has surged by 87% YoY and by 77% QoQ
The quick ratio has declined by 8% year-on-year
The debt rose by 8% since the previous quarter
Key stats
What are the main financial stats of ARVN
Market
Valuations
Earnings
Shares outstanding
72.99M
Market cap
$443.06M
Enterprise value
$372.56M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.63
Price to sales (P/S)
1.03
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.87
Revenue
$426.9M
Gross profit
$426.9M
Operating income
-$95.6M
Net income
-$46.6M
EBIT
-$46M
EBITDA
-$39.8M
Free cash flow
-$252.7M
Per share
Balance sheet
Liquidity
EPS
-$0.66
EPS diluted
-$0.66
Free cash flow per share
-$3.49
Book value per share
$9.6
Revenue per share
$5.89
TBVPS
$13.81
Total assets
$1B
Total liabilities
$341M
Debt
$10.5M
Equity
$660.1M
Working capital
$765.7M
Debt to equity
0.02
Current ratio
4.58
Quick ratio
4.5
Net debt/EBITDA
1.77
Margins
Efficiency
Dividend
EBITDA margin
-9.3%
Gross margin
100%
Net margin
-10.9%
Operating margin
-22.4%
Return on assets
-4.1%
Return on equity
-7.7%
Return on invested capital
-6%
Return on capital employed
-5.8%
Return on sales
-10.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ARVN stock price
How has the Arvinas stock price performed over time
Intraday
-3.5%
1 week
-9%
1 month
-17.97%
1 year
-80.64%
YTD
-68.34%
QTD
-13.53%
Financial performance
How have Arvinas's revenue and profit performed over time
Revenue
$426.9M
Gross profit
$426.9M
Operating income
-$95.6M
Net income
-$46.6M
Gross margin
100%
Net margin
-10.9%
The net margin has surged by 98% year-on-year and by 86% since the previous quarter
Arvinas's operating margin has soared by 96% YoY and by 76% from the previous quarter
The company's net income has surged by 87% YoY and by 77% QoQ
ARVN's operating income has soared by 76% YoY and by 62% from the previous quarter
Price vs fundamentals
How does ARVN's price correlate with its fundamentals
Growth
What is Arvinas's growth rate over time
Valuation
What is Arvinas stock price valuation
P/E
N/A
P/B
0.63
P/S
1.03
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.87
The EPS has soared by 89% YoY and by 76% from the previous quarter
The stock's price to book (P/B) is 84% less than its 5-year quarterly average of 4.0 and 73% less than its last 4 quarters average of 2.3
The company's equity rose by 18% QoQ and by 8% YoY
The P/S is 98% below the 5-year quarterly average of 47.0 and 89% below the last 4 quarters average of 9.5
Arvinas's revenue has soared by 62% from the previous quarter
Efficiency
How efficient is Arvinas business performance
The ROS has soared by 98% YoY and by 86% from the previous quarter
The company's return on invested capital has surged by 88% YoY and by 76% QoQ
ARVN's return on equity has surged by 88% year-on-year and by 77% since the previous quarter
ARVN's return on assets has surged by 87% year-on-year and by 75% since the previous quarter
Dividends
What is ARVN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ARVN.
Financial health
How did Arvinas financials performed over time
ARVN's total assets is 194% more than its total liabilities
Arvinas's total liabilities has decreased by 43% YoY and by 36% from the previous quarter
ARVN's total assets is down by 17% YoY and by 8% from the previous quarter
The debt is 98% smaller than the equity
The company's equity rose by 18% QoQ and by 8% YoY
The debt rose by 8% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.